New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
15:01 EDTPRGO, CPIXPerrigo confirms settlement of generic version of Acetadote patent litigation
Perrigo (TASE) announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote injection brought by Cumberland Pharmaceuticals (CPIX). Under the terms of the settlement, Perrigo can launch a generic version of Acetadote injection upon expiration of the patents in May 2026. In addition, Perrigo entered into an agreement with Cumberland wherein Perrigo can distribute Cumberland sourced authorized generic product upon generic market formation. Acetadote injection, administered intravenously within 8 to 10 hours after ingestion of a potentially hepatotoxic quantity of acetaminophen, is indicated to prevent or lessen hepatic injury and has annual sales of approximately $41M, as measured by Wolters Kluwer. Perrigo's Chairman and CEO Joseph C. Papa stated, "This settlement is another example of our long-term investment in extended product development. As always, Perrigo is committed to making quality healthcare more affordable for our customers."
News For PRGO;CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
17:36 EDTCPIXCumberland reports clinical, regulatory milestones
Subscribe for More Information
06:14 EDTPRGOPerrigo investor sentiment could improve this year, says Deutsche Bank
Deutsche Bank believes Perrigo investor sentiment remains poor and says it "wouldn't wait for things to look perfect" to buy the stock. Deutsche thinks a return to consistent financial results, earnings growth acceleration in Q2 following the close of the Omega acquisition, and a possible investor day around May 5 could drive improved sentiment on the name. It lowered its price target for Perrigo shares to $200 from $204 and keeps a Buy rating on the stock.
February 20, 2015
07:08 EDTPRGOAmerican Academy of Allergy, Asthma and Immunology to hold annual meeting
2015 Annual Meeting of AAAAI is being held in Houston, Texas on February 20-24.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use